490 results on '"Tomai, Fabrizio"'
Search Results
2. Balón liberador de sirolimus en el tratamiento del síndrome coronario agudo y crónico: el estudio PEACE, un subanálisis del registro EASTBOURNE
3. Sirolimus-coated balloon in acute and chronic coronary syndromes: the PEACE study, a subanalysis of the EASTBOURNE registry
4. Impact of renal denervation on patients with coronary microvascular dysfunction: study rationale and design
5. Sirolimus-Coated Balloon in an All-Comer Population of Coronary Artery Disease Patients: The EASTBOURNE Prospective Registry
6. Is Cardiac Shock Wave Therapy an Option for the Treatment of Myocardial Ischemia in Patients with Refractory Angina?
7. Recommendations in pre-procedural imaging assessment for TAVI intervention: SIC-SIRM position paper part 2 (CT and MR angiography, standard medical reporting, future perspectives)
8. Balón recubierto con sirolimus por el tratamiento del síndrome coronario agudo y crónico: subanálisis del estudio EASTBOURNE
9. Impact of High Body Mass Index on Vascular and Bleeding Complications After Transcatheter Aortic Valve Implantation
10. Development and Validation of a Practical Model to Identify Patients at Risk of Bleeding After TAVR
11. Recommendations in pre-procedural imaging assessment for transcatheter aortic valve implantation intervention: Italian Society of Cardiology (SIC)–Italian Society of Medical and Interventional Radiology (SIRM) position paper part 1 (Clinical Indication and Basic Technical Aspects, Heart Team, Role of Echocardiography)
12. IntravaScular Lithotripsy for the Management of UndILatable Coronary StEnt: The SMILE Registry
13. Comparison of Outcomes of Transcatheter Aortic Valve Implantation in Patients ≥85 Years Versus Those
14. Long-Term Follow-Up of Transcatheter Aortic Valve Implantation With Portico Versus Evolut Devices
15. TCT-320 Performance of a Novel Sirolimus-Coated Balloon According to Clinical Presentation: The Eastbourne-Peace Substudy
16. Impact of Predilation Before Transcatheter Aortic Valve Implantation with New-Generation Devices
17. Impact of Insulin-Treated and Noninsulin-Treated Diabetes Mellitus in All-Comer Patients Undergoing Percutaneous Coronary Interventions With Polymer-Free Biolimus-Eluting Stent (from the RUDI-FREE Registry)
18. Polymer-free biolimus-A9-eluting stent performance according to renal impairment: insights from the RUDI-FREE registry
19. Coronary Lithotripsy as Elective or Bail-Out Strategy After Rotational Atherectomy in the Rota-Shock Registry
20. Assessment of the fate of myocardial necrosis by serial myocardial perfusion imaging
21. Clinical performance of a novel sirolimus-coated balloon in coronary artery disease: EASTBOURNE registry
22. Temporal Trends in the Prevalence, Severity, and Localization of Myocardial Ischemia and Necrosis at Myocardial Perfusion Imaging After Myocardial Infarction
23. Impact of coronary revascularization vs medical therapy on ischemia among stable patients with or suspected coronary artery disease undergoing serial myocardial perfusion scintigraphy
24. Biomarkers of Coronary Plaque Composition and Vulnerability
25. The BIOFLOW-III Italian Satellite Registry: 18-month results of the Orsiro stent in an all-comer high-risk population
26. Prognostic impact of location and extent of vessel-related ischemia at myocardial perfusion scintigraphy in patients with or at risk for coronary artery disease
27. Propensity-score-adjusted comparison of Evolut vs. Portico devices for transcatheter aortic valve implantation
28. Multi-imaging evaluation and long-term outcome of a patient with chest pain and an anomalous right coronary artery arising from pulmonary artery: a case report
29. Symptoms-to-emergency-call timing delay in acute coronary syndrome before and during COVID-19: independent predictors and their impact on mortality
30. The History of Research on Coronary Stenting
31. Twenty year follow-up after successful percutaneous balloon mitral valvuloplasty in a large contemporary series of patients with mitral stenosis
32. The impact of UEFA Euro 2020 football championship on Takotsubo Syndrome: Results of a multicenter national registry
33. Reduction in emergency access for acute myocardial infarction during the COVID-19 pandemic: a survey from the greater area of Rome
34. A novel clinically relevant segmentation method and corresponding maximal ischemia score to risk-stratify patients undergoing myocardial perfusion scintigraphy
35. Impact of specific coronary lesions on regional ischemia at single photon emission computed tomography
36. Everolimus-Eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy: the CART (Cardiac Allograft Reparative Therapy) Prospective Multicenter Pilot Study
37. The Incidence and Impact of In-Hospital Bleeding in Patients with Acute Coronary Syndrome during the COVID-19 Pandemic
38. Anatomical localization of arterial thrombosis in patients with acute lower limb ischemia secondary to atrial fibrillation: implications for surgical treatment and outcome
39. Open-Label, Randomized, Placebo-Controlled Evaluation of Intracoronary Adenosine or Nitroprusside After Thrombus Aspiration During Primary Percutaneous Coronary Intervention for the Prevention of Microvascular Obstruction in Acute Myocardial Infarction: The REOPEN-AMI Study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction)
40. Polymer-Free Biolimus-Eluting Stents or Polymer-Based Zotarolimus-Eluting Stents for Coronary Bifurcation Lesions
41. Early and Long-Term Outcomes After Combined Percutaneous Revascularization in Patients With Carotid and Coronary Artery Stenoses
42. 692 Impact of COVID-19 pandemic on in-hospital outcomes for patients with acute coronary syndrome: a propensity-weighted, multicentre study
43. Is Cardiac Shock Wave Therapy an Option for the Treatment of Myocardial Ischemia in Patients with Refractory Angina?
44. Polymer-free biolimus-A9-eluting stent performance according to renal impairment
45. Biomarkers of Coronary Plaque Composition and Vulnerability
46. Evaluation and management of special subgroups after primary percutaneous coronary intervention
47. Long-term clinical follow-up of the multicentre, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: Cortisone plus BMS or DES veRsus BMS alone to EliminAte Restenosis (CEREA-DES)
48. Reply: Bioresorbable Scaffolds in Cardiac Allograft Vasculopathy—Searching for the Holy Grail Facing the challenge of the “Perilous Seat”
49. One-year outcome from an all-comers population of patients with ST-segment elevation myocardial infarction treated with biolimus-eluting stent with biodegradable polymer
50. Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.